Drug Resistant Models
Comprehensive portfolio of drug resistant models representing clinically relevant mechanisms of resistance: 10+ cancer types 25+ key targets 30+ leading...
Continue ReadingKnowledge Library
Cancer Pharmacology Services
Offering a wide range of targeted oncology services and translational models. Our comprehensive platform includes: in vitro biochemical, biophysical, and...
Continue Reading Large Animal Disease Models
Providing a comprehensive panel of large animal disease models across multiple species, including NHP, mini-pig, dog, and rabbit. Models for...
Continue Reading Autoimmune and Inflammatory Disease Models
Comprehensive platform of over 40 disease models (including NHPs and other large animals), covering a wide range of indications and...
Continue Reading Immune Profiling Platform
We offer an extensive panel of cutting-edge immune profiling and biomarker discovery services to support: Target discovery and validation Drug...
Continue Reading Rare Genetic Disease Platform
Oncology & Immunology Services From the generation and characterization of genetically engineered animal models (GEAMs) to colony management and pre-clinical...
Continue Reading Immunology Assays
A comprehensive in vitro platform to accelerate cancer immunotherapy drug discovery: Binding & blocking assessment (via biophysical and biochemical assays,...
Continue Reading
Alpha‐kinase 1 (ALPK1) agonist DF‐006 demonstrates potent efficacy in mouse and primary human hepatocyte models...
WuXi AppTec scientists recently contributed to a research study published in the journal Hepatology, characterizing the efficacy of prodrug DF-006...
Continue Reading
